Aspen Pharmacare. Down 37% From 3rd & Final Sell Call
The final call was on the peak of 29 September. Looking back, good call (hope it helped!).
Down 37% From 3rd & Final Sell Call.
Updates 1 to 3 attached.
Down 37% From 3rd & Final Sell Call.
Updates 1 to 3 attached.
相關出版品
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。